Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03490604
What this trial is testing

Ambulatory Measurement of Physical Activity in Pancreatic Cancer Patients

Who this might be right for
Unresectable Pancreatic Adenocarcinoma
Centre Hospitalier Universitaire Dijon 30
Testing effectiveness (Phase 2)Looking for participantsNCT07157033
What this trial is testing

Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaLocally Advanced Pancreas CancerLocally Advanced Pancreatic Ductal Adenocarcinoma
Xerient Pharma 36
Testing effectiveness (Phase 2)Ended earlyNCT03592264
What this trial is testing

A Phase I/II Study of OBI-3424 in Subjects with Advanced Solid Tumors

Who this might be right for
Solid TumorPancreatic Adenocarcinoma
OBI Pharma, Inc 68
Early research (Phase 1)Ended earlyNCT06528093
What this trial is testing

Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Boehringer Ingelheim 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07561463
What this trial is testing

Sacituzumab Tirumotecan for Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Not applicableStudy completedNCT03003078
What this trial is testing

A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane

Who this might be right for
Unresectable Locally Advanced Pancreatic Carcinoma
OncoSil Medical Limited 50
Testing effectiveness (Phase 2)Looking for participantsNCT04683315
What this trial is testing

PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

Who this might be right for
Pancreatic Cancer
Medical College of Wisconsin 84
Testing effectiveness (Phase 2)Ended earlyNCT00470535
What this trial is testing

Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Roswell Park Cancer Institute 18
Not applicableUnknownNCT03957135
What this trial is testing

Laparoscopic Versus Open Distal Pancreatectomy for Pancreatic Cancer: a Multicenter Randomized Controlled Trial

Who this might be right for
Pancreas Neoplasm Malignant Resectable
Seoul National University Hospital 244
Early research (Phase 1)Study completedNCT04787991
What this trial is testing

Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Cancer Insight, LLC 45
Not applicableUnknownNCT04794140
What this trial is testing

A Clinical Study to Evaluated Which Number of Passes of EUS-FNB is Better for Culturing Primary Cells of PDAC

Who this might be right for
Pancreatic Ductal Adenocarcinoma
The Third Xiangya Hospital of Central South University 60
Not applicableUnknownNCT04922515
What this trial is testing

Pancreatic Ductal Adenocarcinoma - Microbiome as Predictor of Subtypes

Who this might be right for
Pancreatic Cancer
University Medical Center Goettingen 200
Not applicableStudy completedNCT03829748
What this trial is testing

Intermittent Suction Technique in the Diagnosis of Pancreatic Solid Lesions

Who this might be right for
Pancreatic CancerPancreatic Neoplasms
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 33
Testing effectiveness (Phase 2)Study completedNCT02806687
What this trial is testing

Effect of Intratumoral Injection of Gene Therapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
University Hospital, Toulouse 68
Not applicableLooking for participantsNCT05132244
What this trial is testing

Monitoring and Managing Glucose Levels in People With Pancreatic Cancer

Who this might be right for
Pancreatic CancerPDAC - Pancreatic Ductal AdenocarcinomaHyperglycemia
British Columbia Cancer Agency 50
Early research (Phase 1)Study completedNCT03291938
What this trial is testing

IACS-010759 in Advanced Cancers

Who this might be right for
Advanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+22 more
M.D. Anderson Cancer Center 29
Large-scale testing (Phase 3)Study completedNCT00112658
What this trial is testing

Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
UNICANCER 342
Not applicableNo Longer AvailableNCT01980732
What this trial is testing

68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Who this might be right for
Carcinoid TumorsIslet Cell (Pancreatic NET)Other Neuroendocrine Tumors
Andrei Iagaru
Early research (Phase 1)Looking for participantsNCT04389632
What this trial is testing

Sigvotatug Vedotin in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer 1,006
Early research (Phase 1)Study completedNCT05411133
What this trial is testing

Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients

Who this might be right for
Gastrointestinal CancerCholangiocarcinomaLiver Cancer+6 more
Arbele Pty Ltd 33
Next Page